LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease

Sporadic Parkinson's disease (sPD) is a complex multifactorial disorder which etiology remains elusive. Several mechanisms have been described to contribute to PD development namely mitochondrial dysfunction, activation of inflammatory pathways and the deposition of unfolded proteins such as α-...

Full description

Bibliographic Details
Main Authors: A. Raquel Esteves, Diana F. Silva, Diogo Banha, Emanuel Candeias, Beatriz Guedes, Sandra M. Cardoso
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231723001155
_version_ 1827934026519805952
author A. Raquel Esteves
Diana F. Silva
Diogo Banha
Emanuel Candeias
Beatriz Guedes
Sandra M. Cardoso
author_facet A. Raquel Esteves
Diana F. Silva
Diogo Banha
Emanuel Candeias
Beatriz Guedes
Sandra M. Cardoso
author_sort A. Raquel Esteves
collection DOAJ
description Sporadic Parkinson's disease (sPD) is a complex multifactorial disorder which etiology remains elusive. Several mechanisms have been described to contribute to PD development namely mitochondrial dysfunction, activation of inflammatory pathways and the deposition of unfolded proteins such as α-synuclein. Our work shows for the first time that lipopolysaccharide (LPS)-induced activation of innate immunity requires a functional mitochondria and mimics PD pathology in cells. We found in primary mesencephalic neurons that LPS targeted the mitochondria and activated neuronal innate immune responses, which culminated with α-synuclein oligomerization. Moreover, in cybrid cell lines repopulated with mtDNA from sPD subjects with inherent mitochondrial dysfunction and NT2-Rho0 obtained by long-term ethidium bromide exposure, and so without a functional mitochondrial, LPS was not able to further activate innate immunity or increase α-synuclein aggregation.Herein, we showed that mesencephalic neurons are able to activate innate immunity after LPS exposure and this pathway is dependent on mitochondria. Moreover, we disclose that α-synuclein over production is an innate immune response. Our data indicate that mitochondria provide the base for innate immunity activation in idiopathic PD.
first_indexed 2024-03-13T07:32:47Z
format Article
id doaj.art-afa23a29705d44608f9f7c94050897eb
institution Directory Open Access Journal
issn 2213-2317
language English
last_indexed 2024-03-13T07:32:47Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series Redox Biology
spelling doaj.art-afa23a29705d44608f9f7c94050897eb2023-06-04T04:23:43ZengElsevierRedox Biology2213-23172023-07-0163102714LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's diseaseA. Raquel Esteves0Diana F. Silva1Diogo Banha2Emanuel Candeias3Beatriz Guedes4Sandra M. Cardoso5CNC–Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; IIIUC-Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, PortugalCNC–Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; IIIUC-Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, PortugalCNC–Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, PortugalCNC–Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; IIIUC-Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, PortugalCNC–Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, PortugalCNC–Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal; Institute of Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Corresponding author. CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês de Pombal, 3004-517, Coimbra, Portugal.Sporadic Parkinson's disease (sPD) is a complex multifactorial disorder which etiology remains elusive. Several mechanisms have been described to contribute to PD development namely mitochondrial dysfunction, activation of inflammatory pathways and the deposition of unfolded proteins such as α-synuclein. Our work shows for the first time that lipopolysaccharide (LPS)-induced activation of innate immunity requires a functional mitochondria and mimics PD pathology in cells. We found in primary mesencephalic neurons that LPS targeted the mitochondria and activated neuronal innate immune responses, which culminated with α-synuclein oligomerization. Moreover, in cybrid cell lines repopulated with mtDNA from sPD subjects with inherent mitochondrial dysfunction and NT2-Rho0 obtained by long-term ethidium bromide exposure, and so without a functional mitochondrial, LPS was not able to further activate innate immunity or increase α-synuclein aggregation.Herein, we showed that mesencephalic neurons are able to activate innate immunity after LPS exposure and this pathway is dependent on mitochondria. Moreover, we disclose that α-synuclein over production is an innate immune response. Our data indicate that mitochondria provide the base for innate immunity activation in idiopathic PD.http://www.sciencedirect.com/science/article/pii/S2213231723001155Parkinson's diseaseLipopolysaccharidesMitochondrial dysfunctionInnate immunity activationα-synuclein oligomerization
spellingShingle A. Raquel Esteves
Diana F. Silva
Diogo Banha
Emanuel Candeias
Beatriz Guedes
Sandra M. Cardoso
LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease
Redox Biology
Parkinson's disease
Lipopolysaccharides
Mitochondrial dysfunction
Innate immunity activation
α-synuclein oligomerization
title LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease
title_full LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease
title_fullStr LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease
title_full_unstemmed LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease
title_short LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease
title_sort lps induced mitochondrial dysfunction regulates innate immunity activation and α synuclein oligomerization in parkinson s disease
topic Parkinson's disease
Lipopolysaccharides
Mitochondrial dysfunction
Innate immunity activation
α-synuclein oligomerization
url http://www.sciencedirect.com/science/article/pii/S2213231723001155
work_keys_str_mv AT araquelesteves lpsinducedmitochondrialdysfunctionregulatesinnateimmunityactivationandasynucleinoligomerizationinparkinsonsdisease
AT dianafsilva lpsinducedmitochondrialdysfunctionregulatesinnateimmunityactivationandasynucleinoligomerizationinparkinsonsdisease
AT diogobanha lpsinducedmitochondrialdysfunctionregulatesinnateimmunityactivationandasynucleinoligomerizationinparkinsonsdisease
AT emanuelcandeias lpsinducedmitochondrialdysfunctionregulatesinnateimmunityactivationandasynucleinoligomerizationinparkinsonsdisease
AT beatrizguedes lpsinducedmitochondrialdysfunctionregulatesinnateimmunityactivationandasynucleinoligomerizationinparkinsonsdisease
AT sandramcardoso lpsinducedmitochondrialdysfunctionregulatesinnateimmunityactivationandasynucleinoligomerizationinparkinsonsdisease